Lastly, ASK1 exhibits oncogenic activity in pancreatic cancer, where its expression correlates with the histological grade of pancreatic cancer, and its effect is abolished by ASK1 knockdown [107]. The gene discussed is MAP3K5; the disease is familial pancreatic carcinoma.